Skip to content

Tumour Vessel-Targeted LIGHT (TNFSF14) Cytokine

A novel vessel-targeted immunomodulatory agent which promotes tumour vessel normalization

Published: 28th January 2020
Tumour Vessel-Targeted LIGHT (TNFSF14) Cytokine
Please note, header image is purely illustrative. Source: Julio C. Valencia-WikimediaCommons-CC0
  • National phase patents have been filed in the US, EP, China, Malaysia, Korea, Japan, Singapore and Hong Kong; claiming a biomolecule and methods of treatment.
IP Status
  • Patent application submitted
  • Licensing
  • Development partner